Dow Inc. (DOW) · Oct 22, 2026 · Earnings

Dow earnings beat estimates as self-help lifts chemicals profit

Beat — Operating EPS $0.71 vs ~$0.67 consensus

Dow Inc. earnings modestly beat expectations, with pricing and cost actions driving a sharp profit recovery while volumes stayed uneven.

Dow is navigating a prolonged chemicals downturn by shifting toward higher-value applications, cutting costs, shutting higher-cost European capacity, and using Transform to Outperform to target roughly $700 million of 2026 growth and productivity benefits. Those initiatives were already part of the standing story, not a surprise; the new information is that pricing and execution are now producing a much stronger quarter.

Metric3Q263Q25Comparison
Net sales$11.267B$9.973B+13% YoY (Financial Highlights)
GAAP EPS$0.62$0.08+$0.54 YoY (Financial Highlights)
Operating EPS$0.71$(0.19)+$0.90 YoY; vs. ~$0.67 consensus
Operating EBIT$887M$180M+$707M YoY (Financial Highlights)
Operating EBITDA$1.553B$868M+$685M YoY (Financial Highlights)
Operating cash flow$1.839B$1.130B+$709M YoY (Financial Highlights)
Free cash flow$1.133B$566M+$567M YoY (Free Cash Flow reconciliation)

The quarter cleared the market’s bar, but only narrowly. Operating EPS of $0.71 was above the published consensus of roughly $0.67, while revenue of $11.267 billion was broadly around the roughly $11.2 billion expectation. That makes this a genuine earnings beat, but not a wholesale change in the demand outlook. The filing says operating EBIT rose primarily on higher prices and self-help benefits, which more than offset higher raw-material and logistics costs.

The profit recovery is broad, with Packaging & Specialty Plastics doing most of the heavy lifting. Its operating EBIT rose to $585 million from $199 million, helped by higher polyethylene prices and self-help actions. Industrial Intermediates & Infrastructure also swung to $176 million from a $47 million loss, while Performance Materials & Coatings increased to $154 million from $80 million (Operating EBIT by Segment). The mix is encouraging for Dow’s restructuring story, but much of the improvement came from pricing and margin recovery rather than broad volume acceleration: Industrial Intermediates & Infrastructure volumes fell 7%, partly because of Middle East-related disruption, while total company volume declined 1% (Net Sales Variance by Segment and Geographic Region).

The higher-value growth strategy is beginning to show up, though it remains an emerging contributor. Dow cited stronger demand for AI infrastructure and energy applications in Industrial Solutions, alongside volume growth in downstream silicones and consumer, electronics, and home-care applications in Performance Materials & Coatings. Those areas support the company’s attempt to reduce dependence on commodity chemicals, but the quarter still relied heavily on price increases: total local price and product mix rose 14%, versus a 1% volume decline (Net Sales Variance by Segment and Geographic Region).

Cash generation materially strengthens the restructuring case. Operating cash flow reached $1.839 billion and free cash flow $1.133 billion, while management said working capital released more than $400 million during the quarter and debt fell approximately $600 million year to date. This gives Dow more room to fund its portfolio actions and reduce leverage, although the balance sheet still carried $17.5 billion of long-term debt and debt due within one year rose to $745 million at September 30, 2026 (Balance Sheet).

The main limitation is that the filing reinforces an execution story rather than resetting the cycle. Management remains on track for its previously communicated transformation targets, including $700 million of 2026 benefits and approximately $2 billion of total uplift by the end of next year, but the release does not provide a new earnings outlook or demonstrate a volume-led recovery across all businesses. The result is better than expected, yet still dependent on pricing, cost actions, and selective downstream demand.

Bottom line: Dow delivered a modest earnings beat and strong cash quarter, validating its self-help program more than changing the underlying chemicals-cycle story. The business is improving, but the recovery remains more execution- and pricing-led than volume-led.⟧

What to watch next

Q4 earnings report, late January 2027

Original filing on SEC EDGAR

More Dow Inc. news

Dow earnings beat estimates as self-help lifts chemicals profit | DOW Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.